Last reviewed · How we verify
NCT05329181: INTER
Integrated Cognitive Behavioral Treatment for Substance Use and Depressive Symptoms: a Homeless Case Series
NA trial testing Integrated cognitive behavioral treatment in Cognitive Behavioral Therapy in 4 participants. Completed in 31 January 2017.
31 January 2017
Quick facts
| Lead sponsor | Karolinska Institutet |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 4 |
| Start date | 1 June 2016 |
| Primary completion | 31 January 2017 |
| Estimated completion | 31 January 2017 |
Drugs / interventions tested
- Integrated cognitive behavioral treatment
Conditions studied
- Cognitive Behavioral Therapy — all drugs for Cognitive Behavioral Therapy →
Sponsor
Karolinska Institutet
Who can join
Adults 16 to 65, any sex, with Cognitive Behavioral Therapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This case series and feasibility trial evaluated a novel integrated cognitive behavioral treatment, which was adapted specifically for homeless individuals and developed to treat substance use and depressive symptoms simultaneously. The integrated cognitive behavioral treatment was delivered among four homeless individuals enrolled in the Treatment First program (a social services program where treatment is offered in conjunction with temporary transitional housing), who had access to stable and sober housing milieus.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Integrated cognitive behavioral treatment for substance use and depressive symptoms: a homeless case series and feasibility study.
Molander O, Bjureberg J, Sahlin H, Beijer U, et al · · 2023 · cited 5× · PMID 37147667 · DOI 10.1186/s40814-023-01305-2 -
Integrated cognitive behavioral treatment for substance use and depressive symptoms: A homeless case series and feasibility study
Molander O, Bjureberg J, Sahlin H, Beijer U, et al · · 2022 · DOI 10.21203/rs.3.rs-1560793/v1
Verify or expand the search:
- PubMed search for NCT05329181
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cognitive Behavioral Therapy
Currently open trials in the same condition.
- NCT07232823 — Brief Culturally Adapted CBT for OCD · NA · recruiting
- NCT06454695 — Improving Treatment of Major Depressive Disorder by Reducing Negative Future-Oriented Mental Imagery · NA · recruiting
- NCT06521957 — Effectiveness of CBT in Improving Psycho-Neuro-Endocrine Factors in Women Following In Vitro Fertilization Program · NA · recruiting
- NCT05609916 — CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD · NA · recruiting
- NCT04761328 — Fear of Recurrence and Stopping Immunotherapy · NA · recruiting
Other Karolinska Institutet trials
Trials by the same sponsor.
- NCT06359262 — Evaluating the Hope@School Prevention Program · NA · not yet recruiting
- NCT07289490 — Bilateral vs Unilateral Inguinal Hernia Repairs With an Asymptomatic Inguinal Hernia in Bilateral Hernias · NA · not yet recruiting
- NCT06894264 — Emotion Processing and Regulation in People With Intellectual Disability · NA · not yet recruiting
- NCT07494266 — Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited · NA · not yet recruiting
- NCT07442032 — Cardiovascular Phenotypes in Sepsis · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05329181 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karolinska Institutet
- Last refreshed: 14 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05329181.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing